Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 22, 2013

View Archived Issues

Merus Labs International agrees to promote and distribute drug for overactive bladder in Europe

Novel sensor for the rapid intraoperative detection of complete tumor resection

Generation of a human anticancer immune response using a dendritic cell-based vaccine

Uncovering a causative link between endocannabinoid-mediated inflammation and type 2 diabetes

PlantForm secures funding for biosimilar breast cancer product

VAL-083 dose escalation to be accelerated in phase I/II trial

Pharmacokinetic study of onapristone initiated

Lilly presents a novel series of selective CB2 agonists

Lightlake Therapeutics and NIH partner to develop intranasal naloxone for opioid overdose

Catabasis begins phase II trial of CAT-2003 in hypertriglyceridemia and hypercholesterolemia

Oramed recruits for new ORMD-0801 trial

Incyte discloses topline results from phase II proof-of-concept ruxolitinib study

FDA allows marketing of VITEK MS system

ISCO and Duke University sign research agreement

New human influenza virus monoclonal antibodies disclosed

Mount Sinai and Exosome Diagnostics enter collaboration

Galectin Therapeutics raises funds in private placement of restricted stock

SBI Biotech reports new antibodies for autoimmune disorders

Nicotinic acetylcholine receptor ligands patented by Targecept

Memorial Sloan-Kettering Cancer Center begins phase I trial of radiolabeled dasatinib derivative

Novel adenoviral vectors for malaria disclosed by GenVec

Navidea receives NIH grant, enters into agreement with Siemens' PETNET Solutions for imaging agent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...